MEDICATION-INDUCED TAKOTSUBO SYNDROME: INSIGHTS FROM FDA ADVERSE EVENT REPORTING SYSTEM DATABASE

被引：0
|
作者：
Niu, Haiming
Yuan, Yong, Sr.
Li, Jianwei, Sr.
Shi, Ao
Cai, Peng
Chen, Miaolian
Peddibhotla, Bharath
Liang, Hongkai
Feng, Li, Sr.
Li, Mingxing, Sr.
Teng, Catherine
Li, Pengyang
机构：
[1] Virginia Commonwealth Univ, Richmond, VA USA
[2] Zhongshan Peoples Hosp, Zhongshan, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：740 / 740
页数：1
相关论文
共 50 条
  • [31] ETHNIC DIFFERENCE IN ISONIAZID-INDUCED LIVER INJURY; DETECTION BY THE FDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Nakano, Shun
    Kawai, Kana
    Ogawa, Yoshihiro
    Tohkin, Mashiro
    [J]. DRUG METABOLISM REVIEWS, 2015, 47 : 224 - 224
  • [32] Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database
    Yusuke Kan
    Junko Nagai
    Yoshihiro Uesawa
    [J]. Scientific Reports, 11
  • [33] Triptans and serious adverse vascular events: Data mining of the FDA Adverse Event Reporting System database
    Roberto, Giuseppe
    Piccinni, Carlo
    D'Alessandro, Roberto
    Poluzzi, Elisabetta
    [J]. CEPHALALGIA, 2014, 34 (01) : 5 - 13
  • [34] Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database
    Zhu, Jinfeng
    Hu, Mianda
    Liang, Yingshi
    Zhong, Mingjun
    Chen, Zilin
    Wang, Zhenjie
    Yang, Yujia
    Luo, Ziyi
    Zeng, Wenqi
    Li, Jiahui
    Du, Yikuan
    Liu, Yi
    Yang, Chun
    [J]. HELIYON, 2024, 10 (14)
  • [35] Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System Database A Disproportionality Analysis
    Shamloo, Behrooz K.
    Chhabra, Pankdeep
    Freedman, Andrew N.
    Potosky, Arnold
    Malin, Jennifer
    Smith, Sheila Weiss
    [J]. DRUG SAFETY, 2012, 35 (06) : 507 - 518
  • [36] Assessing taxane-associated adverse events using the FDA adverse event reporting system database
    Lao, Dong-Hui
    Chen, Ye
    Fan, Jun
    Zhang, Jian-Zhong
    [J]. CHINESE MEDICAL JOURNAL, 2021, 134 (12) : 1471 - 1476
  • [37] Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database
    Sonawane, Kalyani B.
    Cheng, Ning
    Hansen, Richard A.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (07): : 682 - 690
  • [38] Post-marketing pharmacovigilance study of inclisiran: mining and analyzing adverse event data from the FDA Adverse Event Reporting System database
    Zou, Dan
    Hu, Qiaozhi
    Liu, Ying
    Yu, Lei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024,
  • [39] Serious adverse events with tedizolid and linezolid: pharmacovigilance insights through the FDA adverse event reporting system
    Gatti, Milo
    Fusaroli, Michele
    Raschi, Emanuel
    Moretti, Ugo
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    [J]. EXPERT OPINION ON DRUG SAFETY, 2021, 20 (11) : 1421 - 1431
  • [40] Are dizziness-related symptoms signals for suboptimal treatment of hypothyroidism? New insights from the FDA adverse event reporting system (FAERS) database
    Carnovale, Carla
    Battini, Vera
    Mazhar, Faizan
    Mosini, Giulia
    Gringeri, Michele
    Vicenzi, Andrea
    Clementi, Emilio
    Radice, Sonia
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (05) : 733 - 734
12345